31
First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
Condition(s):Tumor, SolidLast Updated:February 1, 2023Recruiting
First in Human: 7278 Clinical Trials, Page 4 of 728
Hide Studies Not Open or Pending
32
First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
Condition(s):Age-Related Macular DegenerationLast Updated:April 1, 2016Completed
33
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Condition(s):Solid TumorsLast Updated:September 9, 2020Unknown status
34
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Condition(s):Solid TumorLast Updated:August 3, 2022Recruiting
35
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI
Condition(s):COVID-19Last Updated:March 10, 2023Completed
36
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer’s Disease (AD)
Condition(s):Alzheimer’s DiseaseLast Updated:March 28, 2023Recruiting
37
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Condition(s):PIK3CA Mutation; Solid Tumor, Adult; HER2-negative Breast Cancer; Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; Unresectable Solid Tumor; Hormone Receptor Positive TumorLast Updated:March 8, 2023Not yet recruiting
38
First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Immediate Breast Reconstruction After Mastectomy for Cancer
Condition(s):Breast Cancer Female; Breast Cancer Prevent; Breast ReconstructionLast Updated:July 19, 2022Recruiting
39
First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:June 14, 2017Completed
40
A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:August 21, 2019Completed